ATLANTA, March 07, 2017 (GLOBE NEWSWIRE) -- Alimera Sciences (NASDAQ:ALIM), a leader in the commercialization,
research and development of prescription ophthalmic pharmaceuticals, today announced that Chief Executive Officer, Dan Myers, will
present at the 29th Annual ROTH Conference, to be held March 12-15, 2017 at the Ritz Carlton, Orange County, CA. The Company's
presentation will take place Wednesday, March 15, 2017, at 10:00 AM Pacific Time.
A live broadcast of the conference presentation will be available. To access the broadcast, go to the "Investor
Relations" section of the Company's website at www.alimerasciences.com. A replay of the conference presentation will also be available.
About Alimera Sciences
Alimera Sciences, founded in June 2003, is a pharmaceutical company that specializes in the commercialization,
research and development of prescription ophthalmic pharmaceuticals. Alimera is presently focused on diseases affecting the back of
the eye, or retina, because these diseases are not well treated with current therapies and will affect millions of people in our
aging populations. Alimera's commitment to retina specialists and their patients is manifest in its product and in its development
portfolio designed to treat early- and late-stage diseases. For more information, please visit www.alimerasciences.com.
Contact:
CG CAPITAL
877.889.1972
investorrelations@cg.capital
cg.capital
